Globus Medical, Inc. Class A (GMED) Earnings Call Analysis
NYSE · Healthcare · Medical Devices
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Globus Medical (GMED) Q1 2026: Margin Expansion Drives 65% EPS Growth Amid Enabling Tech Shift
May 08, 2026
-
Globus Medical (GMED) Q4 2025: Gross Margin Expands 210bps as Enabling Tech and Synergy Actions Drive Leverage
February 25, 2026
-
Globus Medical (GMED) Q3 2025: EBITDA Margin Climbs to 35.3% as U.S. Spine and Nevro Integration Drive Upside
November 07, 2025
-
Globus Medical (GMED) Q2 2025: Nevro Adds $95M, Accelerating Musculoskeletal Platform Integration
August 08, 2025
-
Globus Medical (GMED) Q1 2025: Free Cash Flow Surges 493% Despite 31% Enabling Tech Drop
July 05, 2025